Jaundice, ascites, and encephalopathy

2021 ◽  
pp. 556-566
Author(s):  
Alexandra Shingina ◽  
Anne M. Larson

The development of jaundice, ascites, or encephalopathy in the context of chronic liver disease or malignancy is an ominous indicator of advanced disease. In two studies of individuals admitted to hospital with jaundice, up to 42% of patients with malignancy and up to 23% with cirrhosis died during their first admission. The necessity of a willingness to adopt a ‘palliative approach’ to the care of such individuals is obvious. This chapter discusses three features of liver impairment that may be encountered in those for whom palliative care is appropriate.

Author(s):  
Jeremy Keen

For many people, jaundice will occur as part of an episode of acute, self-limiting, viral hepatitis but in the context of chronic hepatic disease or malignancy, the development of jaundice or ascites is usually an ominous indicator of advanced disease. In two reported studies of individuals admitted to hospital with jaundice, 24% and 42% of patients with malignancy and 23% with cirrhosis died during their first admission. The necessity of a willingness to adopt a ‘palliative approach’ to the care of such individuals is obvious. This chapter discusses three features of liver impairment that may be encountered in those for whom palliative care is appropriate but the review of ascites concentrates on causes other than cirrhosis and portal hypertension.


2019 ◽  
Vol 11 (3) ◽  
pp. 218-227
Author(s):  
Hazel Woodland ◽  
Ben Hudson ◽  
Karen Forbes ◽  
Anne McCune ◽  
Mark Wright

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advanced disease have a symptom burden comparable to or higher than that experienced in other life-limiting illnesses. While evidence is limited, there is growing recognition that care of patients with advanced disease needs to improve. Many factors limit widespread provision of good palliative care to these patients, including the unpredictable trajectory of chronic liver disease, the misconception that palliative care and end-of-life care are synonymous, lack of confidence in prescribing and lack of time and resources. Healthcare professionals managing these patients need to develop the skills to ensure effective delivery of core palliative care, with referral to specialist palliative care services reserved for those with complex needs. Core palliative care is best delivered by the hepatology team in parallel with active disease management. This includes ensuring that discussions about disease trajectory and advance care planning occur alongside active management of disease complications. Liver disease is strongly associated with significant social, psychological and financial hardships for patients and their carers; strategies that involve the wider multidisciplinary team at an early stage in the disease trajectory help ensure proactive management of such issues. This review summarises the evidence supporting palliative care for patients with advanced chronic liver disease, presents examples of current best practice and provides pragmatic suggestions for how palliative and disease-modifying care can be run in parallel, such that patients do not miss opportunities for interventions that improve their quality of life.


2021 ◽  
Author(s):  
Hannah Fox ◽  
Eleanor Hendicott ◽  
Debashis Haldar ◽  
Chris Corbett ◽  
Hazel Coop

2001 ◽  
Vol 120 (5) ◽  
pp. A7-A7
Author(s):  
S ROSS ◽  
S MASCHERETTI ◽  
H HINRICHSEN ◽  
P BUGGISCH ◽  
U FOELSCH ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document